NCT03313687Recruiting
SafeTy and Outcome of contemPorary Treatment Strategies for Cardiogenic SHOCK
SafeTy and Outcome of contemPorary Treatment Strategies for Cardiogenic SHOCK - an International, Observational Registry
Source: ClinicalTrials.gov · Last updated 7 Oct 2021 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
International, observational registry to investigate the outcome in patients with cardiogenic shock. The primary aim of this study is to investigate the clinical outcome of patients in cardiogenic shock.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 2500 (estimated)
- First submitted
- 14 Oct 2017
- Start date
- 1 Sept 2017
- Primary completion date
- 31 Dec 2030
- Lead sponsor
- Universitätsklinikum Hamburg-Eppendorf
- NCT number
- NCT03313687
What you commit to
- Study type: Observational
- Planned participants: 2500
- From 1 Sept 2017 to the primary completion date, 31 Dec 2030
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Age
- Age ≤17 years.
Who the study is looking for
- Patients with cardiogenic shock treated at a tertiary care hospital.
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| University Heart Center Coordinator of this site? Confirm its status | Hamburg | Germany | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.